Management and clinical-outcome of juxta-articular osteoid osteoma lesions

关节旁骨样骨瘤病变的治疗和临床结果

阅读:1

Abstract

INTRODUCTION: Osteoid osteoma (OO) is a benign intra-osseous lesion. The lesion is painful and usually diagnosed by x-ray, computed tomography (CT) or magnetic resonance imaging (MRI). When the lesion is juxta-articular or intra-capsular, the symptoms may present differently than the typical OO lesion and make diagnosis more challenging. Proximity to articular cartilage may make the treatment with radiofrequency ablation more dangerous. This study presents an 11-year experience in managing juxta-articular osteoid osteoma (JAOO) including long-term follow-up, while using CT-guided radiofrequency ablation (CT-RFA). METHODS: All patients diagnosed with OO and managed with CT-RFA between 2010 and 2020 were reviewed. Those with a lesion that was intra-capsular or less than 2 cm from the articular cartilage were included. Charts and all imaging studies were evaluated, and patients were interviewed by phone for any persistent or recurrent symptoms. RESULTS: There were 168 patients with OO during this period and 59 met the criteria for inclusion. Forty-four (75%) were male and median age at the time of ablation was 20.7 years (range 3-59 years). Thirteen (22%) had active growth plates during ablation. Three patients (5%) required a repeat ablation for non-resolving pain. None of the 13 children with open physes had growth disturbance of the affected limb after ablation. In 3 patients, the typical OO pain resolved but an activity related pain persisted. One of them had articular damage that may be related to the CT-RFA. CONCLUSION: JAOO may present challenges for diagnosis and treatment and CT-RFA is the current standard for treatment. Despite proximity to the cartilage and physis, careful attention to technique showed only one injury to these structures in this series of 59 patients.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。